Lipoxygenase and cyclooxygenase inhibiting compounds
AssigneeAbbott Laboratories
InventorsClint D. W. Brooks, Andrew O. Stewart, Anwer Basha, Randy L. Bell
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Laboratories
InventorsClint D. W. Brooks, Andrew O. Stewart, Anwer Basha, Randy L. Bell
Estimating the term…
Compounds having the structure ##STR1## or a pharmaceutically acceptable salt thereof have activity as inhibitors of cylooxygenase and 5-lipoxygenase, reduce the biosynthesis of leukotrienes B.sub.4, C.sub.4, D.sub.4, and E.sub.4 and cylooxygenase products such as prostaglandins and thromboxane and are useful in the treatment of inflammatory and allergic disease states. The compounds have the structure indicated above wherein A is selected from (a) optinally substituted carbocyclic aryl, (b) optinally substituted furyl, (c) optinally substituted benzo[b]furyl, (d) optinally substituted thienyl, (e) optinally substituted pyridyloxy, (f) optinally substituted pyridylalkyl, (g) optinally substituted benzo[b]thienyl, (h) optinally substituted pyridyl, (i) optinally substituted quinolyl, and (j) optinally substituted indolyl; X is selected from (a) optionally substituted alkyl, (b) optinally substituted alkenyl, and (c) optinally substituted alkynyl; R.sup.1 and R.sup.2 are independently selected from hydrogen, hydroxy, and alkyl; and Z is a residue of a non-steroidal anti-inflammatory drug of the general formula Z--COOH.
A compound or pharmaceutically acceptable salt thereof of formula ##STR57## wherein A is selected from the group consisting of
Dependencies are inferred from the claim text.